The use of molecular imaging to determine which patient should receive which targeted therapy
Staging and diagnosis of lung cancer: methods and challenges
What are the limitations of magnetic resonance imaging (MRI) in prostate cancer diagnosis?
Developments in prostate cancer at the EAU video session
Trial of LHRHa, abiraterone and enzalutamide: filling an unmet need in prostate cancer therapy